Foghorn Therapeutics Inc. Increase (Decrease) in Accrued Liabilities
Foghorn Therapeutics Inc. (FHTX) reported Increase (Decrease) in Accrued Liabilities of -$3.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $1.06M, a 47.45% decline year-over-year.
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$4.46M.
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $1.44M.
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $1.16M, a 76.72% decline year-over-year.
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $2.20M.
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$564.00K.
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$1.80M, a 224.71% decline from fiscal 2022.
- Foghorn Therapeutics Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $1.44M, a 45.68% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$3.40M 10-Q · filed 2026-08-06 | -$1.96M derived: sum of 3 quarters · filed 2026-08-06 | -$805.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$4.46M 10-Q · filed 2026-05-07 | -$3.02M derived: sum of 2 quarters · filed 2026-05-07 | -$1.87M derived: sum of 3 quarters · filed 2026-05-07 | $153.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $2.59M derived: sum of 2 quarters · filed 2026-03-11 | $4.61M derived: sum of 3 quarters · filed 2026-08-06 | $2.20M 10-K · filed 2026-03-11 |
| 2025-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.18M derived: sum of 2 quarters · filed 2026-08-06 | $769.00K 10-Q · filed 2025-11-05 | -$1.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$388.00K 10-Q · filed 2026-08-06 | -$2.81M derived: sum of 3 quarters · filed 2026-08-06 | $2.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.41M 10-Q · filed 2026-05-07 | -$4.83M derived: sum of 2 quarters · filed 2026-05-07 | $141.00K derived: sum of 3 quarters · filed 2026-05-07 | -$163.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $2.55M derived: sum of 2 quarters · filed 2026-03-11 | $2.24M derived: sum of 3 quarters · filed 2026-03-11 | -$564.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $4.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.67M derived: sum of 2 quarters · filed 2025-11-05 | $1.86M 10-Q · filed 2025-11-05 | $2.19M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$3.11M 10-Q · filed 2025-08-05 | -$2.78M derived: sum of 3 quarters · filed 2025-08-05 | -$2.09M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$2.81M 10-Q · filed 2025-05-14 | -$2.48M derived: sum of 2 quarters · filed 2025-05-14 | -$1.79M derived: sum of 3 quarters · filed 2025-05-14 | -$2.45M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.02M derived: sum of 2 quarters · filed 2025-03-06 | $357.00K derived: sum of 3 quarters · filed 2025-03-06 | -$1.80M 10-K · filed 2025-03-06 |
| 2023-09-30 | $690.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $25.00K derived: sum of 2 quarters · filed 2024-11-04 | -$2.13M 10-Q · filed 2024-11-04 | -$1.24M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | -$665.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.82M 10-Q · filed 2024-08-08 | -$1.93M derived: sum of 3 quarters · filed 2024-08-08 | $77.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$2.15M 10-Q · filed 2024-05-06 | -$1.26M derived: sum of 2 quarters · filed 2024-05-06 | $742.00K derived: sum of 3 quarters · filed 2024-05-06 | $1.83M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.90M derived: sum of 2 quarters · filed 2024-03-07 | $3.98M derived: sum of 3 quarters · filed 2024-03-07 | $1.44M 10-K · filed 2024-03-07 |
| 2022-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.09M derived: sum of 2 quarters · filed 2023-11-02 | $547.00K 10-Q · filed 2023-11-02 | $2.95M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.46M 10-Q · filed 2023-08-04 | $945.00K derived: sum of 3 quarters · filed 2023-08-04 | $2.90M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | -$2.54M 10-Q · filed 2023-05-08 | -$142.00K derived: sum of 2 quarters · filed 2023-05-08 | $1.81M derived: sum of 3 quarters · filed 2023-05-08 | $2.72M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $4.35M derived: sum of 2 quarters · filed 2023-03-09 | $5.26M derived: sum of 3 quarters · filed 2023-03-09 | $2.65M 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.86M derived: sum of 2 quarters · filed 2022-11-08 | $253.00K 10-Q · filed 2022-11-08 | $3.65M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $910.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.70M 10-Q · filed 2022-08-09 | $1.69M derived: sum of 3 quarters · filed 2022-08-09 | $676.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$2.61M 10-Q · filed 2022-05-09 | $783.00K derived: sum of 2 quarters · filed 2022-08-09 | -$234.00K derived: sum of 3 quarters · filed 2022-08-09 | $602.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | $3.39M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $2.38M derived: sum of 2 quarters · filed 2022-08-09 | $3.21M derived: sum of 3 quarters · filed 2022-08-09 | $3.19M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | -$1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$181.00K derived: sum of 2 quarters · filed 2021-11-09 | -$198.00K 10-Q · filed 2021-11-09 | $997.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $836.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $819.00K 10-Q · filed 2021-08-10 | $2.01M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | -$17.00K 10-Q · filed 2021-05-11 | $1.18M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $2.14M 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $942.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |